Also categorized in Business of Medicine:
The first U.S. trials in people put CRISPR to the test in 2019
x hide permanently

Regenstrief Research Scientist to Lead American Delirium Society for 2023-24 Term


Photo: Regenstrief

Regenstrief Research Scientist Noll Campbell, PharmD, M.S., has been voted president-elect of the American Delirium Society (ADS) by the board of directors. Dr. Campbell will be installed into office in conjunction with the society’s national conference in June of 2023.

Delirium is a sudden change in brain function leading to confusion and reduced awareness of a person’s surroundings. People in the intensive care unit often experience delirium.

Dr. Campbell’s research is focused on the recognition and measurement of adverse cognitive effects of medications in older adults with acute and chronic cognitive impairment ...